Pfizer Advancing Once-Daily Danuglipron For Obesity

Pfizer
Pfizer updated investors on the development of danuglipron • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category